Pemigatinib FGFR Inhibitor Generic Cholangiocarcinoma Tablet

Pemigatinib is an inhibitor made to hit the Fusion Gene Receptor family, also known as FGFR. It mostly treats cholangiocarcinoma, which is marked by FGFR2 fusions. The drug really keeps the FGFR signaling in check.

Pemigatinib comes in tablets at 4.5, 9, and 13.5 mg doses. The 13.5 mg ones are what doctors usually recommend. You’re supposed to take one 13.5 mg tablet every day for 14 days out of every 21-day cycle.

Each bottle has 14 tablets, which is super handy for keeping up with the 21-day cycle.